Halozyme Therapeutic (HALO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 129,085 | 55,921 | 19,714 | -6,103 | -72,240 |
| Depreciation Amortization | 18,259 | 13,501 | 8,866 | 4,344 | 4,083 |
| Accounts receivable | -38,288 | -3,109 | 22,041 | 29,693 | -29,437 |
| Other Working Capital | -107,853 | -77,777 | -37,822 | -6,794 | -54,535 |
| Other Operating Activity | 54,251 | 15,998 | -14,349 | -25,984 | 66,706 |
| Operating Cash Flow | $55,454 | $4,534 | $-1,550 | $-4,844 | $-85,423 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 79,782 | 19,857 | 49,899 | 37,485 | -1,509 |
| PPE Investments | -1,428 | 56 | 109 | 624 | -4,040 |
| Investing Cash Flow | $78,354 | $19,913 | $50,008 | $38,109 | $-5,549 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 0 | 0 | 0 | 447,350 |
| Debt Repayment | -19,560 | -19,560 | -19,560 | -16,699 | -108,082 |
| Common Stock Issued | 63,393 | 50,645 | 38,099 | 19,717 | 14,224 |
| Common Stock Repurchased | -150,117 | -109,970 | -53,570 | -51,574 | -199,998 |
| Other Financing Activity | 0 | 0 | 0 | -68 | -279 |
| Financing Cash Flow | $-106,284 | $-78,885 | $-35,031 | $-48,624 | $153,215 |
| Beginning Cash Position | 120,679 | 120,679 | 120,679 | 120,679 | 58,436 |
| End Cash Position | 148,203 | 66,241 | 134,106 | 105,320 | 120,679 |
| Net Cash Flow | $27,524 | $-54,438 | $13,427 | $-15,359 | $62,243 |
| Free Cash Flow | |||||
| Operating Cash Flow | 55,454 | 4,534 | -1,550 | -4,844 | -85,423 |
| Capital Expenditure | -2,504 | -805 | -629 | -114 | -4,040 |
| Free Cash Flow | 52,950 | 3,729 | -2,179 | -4,958 | -89,463 |